Design of phase II trials in congestive heart failure.
DeMets
D L
DL
Department of Biostatistics and Medical Informatics, University of Wisconsin-Madison, 53792, USA.
D002316:Cardiotonic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D017322:Clinical Trials, Phase II as Topic / Q000706:statistics & numerical data*; D003627:Data Interpretation, Statistical; D004305:Dose-Response Relationship, Drug; D015507:Drugs, Investigational / Q000009:adverse effects / Q000627:therapeutic use*; D006333:Heart Failure / Q000188:drug therapy* / Q000401:mortality; D006801:Humans; D012107:Research Design; D016019:Survival Analysis
D002316:Cardiotonic Agents; D015507:Drugs, Investigational